BTOG 2018 | Does the UK need a National Optimal Lung Cancer Pathway?
Neal Navani
Long waits for and between treatments, leading to worse outcomes for patients, are unacceptable. Improved care pathways are required to streamline the treatment journey. In this interview, Neal Navani, PhD, of University College London Hospitals NHS Foundation Trust, London, UK, discusses the new National Optimal Lung Cancer Pathway (NOLCP). This video was recorded at the British Thoracic Oncology Group (BTOG) Annual Conference 2018, held in Dublin, Ireland.
Similar topics
Related videos

BTOG 2020: what to expect
Sanjay Popat

Pharmacy perspective: pembrolizumab monotherapy 6 weekly dosing
Rob Duncombe

Cancer treatment: major milestones & what's next in the 2020s
John Wagstaff

Minimizing the risk of steroid-induced hyperglycemia in NSCLC patients receiving immunotherapy
Islam Elkonaissi

SB8: a bevacizumab biosimilar for NSCLC
Martin Reck
24th January 2018
More from Neal Navani